USANA Health Sciences (USNA) Tops Q3 EPS by 6c

Go back to USANA Health Sciences (USNA) Tops Q3 EPS by 6c

USANA (USNA) PT Raised to $80 at Pivotal Research

October 25, 2017 12:30 PM EDT

Pivotal Research analyst Timothy Ramey raised his price target on USANA Health Sciences Inc. (NYSE: USNA) to $80.00 (from $70.00) while maintaining a Buy rating following better-than-expected Q3 EPS on 3% sales growth with F/X not a factor for the first time in three years.

Active... More